Is Aspirin the True Protective Therapy in Coronavirus Disease 2019 Patients? | Anesth Analg;133(3): e41, 2021 09 01. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

WHO COVID-19 Research Database

News/Update/Help

Advanced Search

The WHO Covid-19 Research Database is a resource created in response to the Public Health Emergency of International Concern (PHEIC). Its content remains searchable and spans the time period March 2020 to June 2023. Since June 2023, manual updates to the database have been discontinued.

Is Aspirin the True Protective Therapy in Coronavirus Disease 2019 Patients?

Mourad, Jean-Jacques; Suhl, Jaehyo.

Mourad JJ; Department of Internal Medicine and European Society of Hypertension Excellence Centre, Groupe hospitalier Paris Saint-Joseph, Paris, France, jjmourad@ghpsj.fr.

Anesth Analg ; 133(3): e41, 2021 09 01.

Article in English | MEDLINE | ID: covidwho-1360630

Subject(s)

Aspirin; COVID-19; Anti-Inflammatory Agents, Non-Steroidal; Aspirin/adverse effects; Humans; Platelet Aggregation Inhibitors; SARS-CoV-2

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Aspirin / COVID-19 Limits: Humans Language: English Journal: Anesth Analg Year: 2021 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Aspirin / COVID-19 Limits: Humans Language: English Journal: Anesth Analg Year: 2021 Document Type: Article